Indigestion follows €433m Arkema sale
Groupe Bruxelles Lambert sold its entire 10.01% stake in French chemicals firm Arkema on Wednesday following a strong run in the stock price over the last six months and since the company reported results last week. It traded weakly following the tightly-priced deal, but bankers and analysts away from the deal remain bullish on the stock and expect the indigestion to clear soon.
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org